Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diabetes mellitus 7 endocrinologydiseases
hyperglycemia 1 endocrinologydiseases
type 2 diabetes mellitus 2 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 119 Cardiovascular DisordersComparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic
diabetes mellitus 165 outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysisNuo LiYe-Gui YangMeng-Hua
diabetes mellitus 3013 Intervention (PCI). For example, the PRESTO trial showed that despite advances in interventional techniques, diabetes mellitus remained a significant predictor of adverse clinical events after PCI [[1], [2]]. Later on, it was shown
diabetes mellitus 4115 observational studies were searched from Medline/PubMed, EMBASE and the Cochrane databases using the words ‘ diabetes mellitus and percutaneous coronary intervention/PCI’ or ‘insulin-treated and non-insulin treated diabetes
diabetes mellitus 4225 mellitus and percutaneous coronary intervention/PCI’ or ‘insulin-treated and non-insulin treated diabetes mellitus and PCI’. The term ‘angioplasty’ and the abbreviations ‘T2DM and DM’ were also used. Reference
diabetes mellitus 10443 [[15]]19195269OS1 yearSilber 2013 [[16]]6281903RCT2 yearsAbbreviations: NITDM non-insulin treated diabetes mellitus , NDM non-diabetes mellitus, RCT randomized controlled trials, OS observational studiesAs shown in Table 2,
diabetes mellitus 10470 [[15]]19195269OS1 yearSilber 2013 [[16]]6281903RCT2 yearsAbbreviations: NITDM non-insulin treated diabetes mellitus, NDM non- diabetes mellitus , RCT randomized controlled trials, OS observational studiesAs shown in Table 2, this meta-analysis
hyperglycemia 20190 factors such as female gender, insulin resistance, coronary plaque vulnerability and post challenge hyperglycemia to be responsible for these adverse clinical outcomes following PCI [[20]–[23]]. However, this current
type 2 diabetes mellitus 112 Cardiovascular DisordersComparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic
type 2 diabetes mellitus 158 clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysisNuo LiYe-Gui YangMeng-Hua

You must be authorized to submit a review.